2023 annual financial data
Lakewood-Amedex Biotherapeutics 2023 Operating margin
Lakewood-Amedex Biotherapeutics 2023 operating margin with verified reported va…
Direct answer
Operating margin was Not calculable.
Operating income was -8,636,719 USD and net income was -8,281,960 USD.
Operating cash flow was -6,816,114 USD.
Get free Lakewood-Amedex Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -8,636,719 USD
- Net income
- -8,281,960 USD
- Operating cash flow
- -6,816,114 USD
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Net marginView Operating cash flow marginView all Lakewood-Amedex Biotherapeutics financial years